Clinical trial
Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer
NCT00154700 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00154700 |
|---|---|
| Title | Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer |
| Official title | A Phase II Study of Twice Weekly Paclitaxel, Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid in the Treatment of Recurrent or Metastatic Esophageal Cancer |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Cisplatin, 5-Fu, Folic Acid |
| Enrollment | 40 |
| Start date | Jan 1, 2001 |
| Completion | Jul 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 20, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: